Sei Investments CO Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $3.44 Million - $3.61 Million	-23,725 Reduced 43.51%	30,806 $4.66 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $3.09 Million - $5.43 Million	37,202 Added 214.68%	54,531 $7.95 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $320,773 - $416,468	2,914 Added 20.22%	17,329 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $842,818 - $1.25 Million	8,451 Added 141.7%	14,415 $1.99 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $643,810 - $904,720	-6,513 Reduced 52.2%	5,964 $828,000
Q2 2021 Aug 06, 2021	BUY	$65.78 - $105.02 $31,377 - $50,094	477 Added 3.98%	12,477 $1.22 Million
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $230,972 - $330,758	3,605 Added 42.94%	12,000 $820,000
Q4 2020 Feb 08, 2021	SELL	$65.07 - $98.24 $212,453 - $320,753	-3,265 Reduced 28.0%	8,395 $720,000
Q3 2020 Nov 06, 2020	BUY	$59.04 - $77.95 $408,556 - $539,414	6,920 Added 145.99%	11,660 $758,000
Q2 2020 Aug 17, 2020	BUY	$29.01 - $74.23 $137,507 - $351,850	4,740 New	4,740 $347,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.